Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,349
Award facts
- Contract value 100% obligated
- $28,348.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,348.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime contractor supporting military and veteran healthcare systems through the DLA Medical Supply Chain. Dupixent (dupilumab) is a specialty biologic medication used to treat various inflammatory conditions including atopic dermatitis and asthma. This delivery order exemplifies the company's role in supplying brand-name specialty pharmaceuticals and medical supplies to support Defense Health Agency requirements and other federal healthcare customers. The IDC vehicle under which this order was placed enables flexible procurement of a comprehensive range of pharmaceutical products and medical commodities to meet global military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA0W7?
SPE2DR26FA0W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FA0W7 worth?
The government has obligated $28,349 on SPE2DR26FA0W7.
Is contract SPE2DR26FA0W7 an order under another contract?
Yes. SPE2DR26FA0W7 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0W7 competed?
The extent of competition for SPE2DR26FA0W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award